Clinical Trials Logo

Filter by:
NCT ID: NCT00257972 Completed - Bipolar Disorder Clinical Trials

Study of Aripiprazole in Patients With Bipolar I Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to compare the efficacy of aripiprazole with placebo in combination with lithium or valproate monotherapy, in the treatment of bipolar I patients with manic or mixed episodes.

NCT ID: NCT00257660 Completed - Cervical Dystonia Clinical Trials

Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia

Start date: October 10, 2005
Phase: Phase 3
Study type: Interventional

The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.

NCT ID: NCT00257205 Completed - Melanoma Clinical Trials

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Start date: March 2006
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multi-national, open-label, 2-arm randomized study in patients with surgically incurable metastatic melanoma who have received no prior chemotherapy, or biochemotherapy for the treatment of metastatic disease. The primary objective of this trial is to compare overall survival for patients with advanced melanoma who are randomized to receive CP-675,206 with that of patients who are randomized to receive either dacarbazine or temozolomide (investigator choice)

NCT ID: NCT00256126 Completed - Clinical trials for Growth Hormone Deficiency

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Start date: May 31, 2005
Phase: Phase 4
Study type: Interventional

The study aims at identifying the predictive markers after one month of Saizen therapy in Growth Hormone Deficiency (GHD) and Turner Syndrome children.

NCT ID: NCT00253955 Completed - Pneumonia Clinical Trials

Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia

Start date: June 2003
Phase: Phase 3
Study type: Interventional

Primary Objective: - The primary objective of the study is to demonstrate the non-inferiority in clinical efficacy at the test of cure (TOC) visit planned 5-7 days after treatment completion of levofloxacin 750 mg once daily (od) in comparison with piperacillin/tazobactam 4 g/500 mg every 8 hours in treating adult patients suffering from mild to moderate hospital-acquired pneumonia. Secondary Objectives: The secondary objectives of the study are: - To assess the bacteriological efficacy at the test of cure (TOC) visit - To assess the clinical and bacteriological efficacy at the end of study (EOS) visit, 28 to 32 days after treatment ends - To assess the tolerability of both drugs

NCT ID: NCT00251979 Completed - Clinical trials for Gastrointestinal Hemorrhage

A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer

Start date: October 2005
Phase: Phase 3
Study type: Interventional

This study is being carried out to see if constant 3 days infusion of Nexium is effective in preventing rebleeding after an endoscopic treatment.

NCT ID: NCT00251719 Completed - Esophagitis, Reflux Clinical Trials

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Start date: December 2005
Phase: Phase 3
Study type: Interventional

This is a study to assess the efficacy and safety of 8 weeks of treatment with Dexlansoprazole modified release (MR)(60 mg daily and 90 mg daily) compared to Lansoprazole (30 mg daily) in healing subjects with endoscopically proven erosive esophagitis.

NCT ID: NCT00251082 Completed - Postmenopause Clinical Trials

Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

Start date: December 2005
Phase: Phase 3
Study type: Interventional

To demonstrate efficacy of continuous combined 0.5 mg estradiol and 2.5 mg dydrogesterone versus placebo in the treatment of vasomotor symptoms after a treatment period of 3 months and to investigate the bleeding pattern over a treatment period of one year

NCT ID: NCT00249730 Completed - Impotence Clinical Trials

Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.

Start date: October 2005
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of Viagra dose titration to 100mg versus 50mg in men with erectile dysfunction, based on responses to the IIEF questionnaire as measured at the beginning and at the end of double blind treatment, comparing the group titrated to 100mg vs. the group maintained on 50mg.

NCT ID: NCT00249249 Completed - Dyslipidemia Clinical Trials

Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

Start date: October 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of pitavastatin with that of atorvastatin.